These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study. Valenzuela-Vallejo L; Chrysafi P; Kouvari M; Guatibonza-Garcia V; Mylonakis SC; Katsarou A; Verrastro O; Markakis G; Eslam M; Papatheodoridis G; Mingrone G; George J; Mantzoros CS Metabolism; 2023 Nov; 148():155694. PubMed ID: 37757973 [TBL] [Abstract][Full Text] [Related]
9. Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study. Kouvari M; Valenzuela-Vallejo L; Guatibonza-Garcia V; Polyzos SA; Deng Y; Kokkorakis M; Agraz M; Mylonakis SC; Katsarou A; Verrastro O; Markakis G; Eslam M; Papatheodoridis G; George J; Mingrone G; Mantzoros CS Metabolism; 2023 Oct; 147():155666. PubMed ID: 37527759 [TBL] [Abstract][Full Text] [Related]
10. Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease. Armandi A; Bugianesi E Eur J Intern Med; 2024 Apr; 122():20-27. PubMed ID: 38262842 [TBL] [Abstract][Full Text] [Related]
11. Small intestinal bacterial overgrowth in obese patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: a cross-sectional study. Ortiz-López N; Madrid AM; Aleman L; Zazueta A; Smok G; Valenzuela-Pérez L; Poniachik J; Beltrán CJ Front Med (Lausanne); 2024; 11():1376148. PubMed ID: 38854668 [TBL] [Abstract][Full Text] [Related]
12. The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients. Paklar N; Mijic M; Filipec-Kanizaj T Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002096 [TBL] [Abstract][Full Text] [Related]
14. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice. Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320 [TBL] [Abstract][Full Text] [Related]
15. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone. Duman S; Kuru D; Gumussoy M; Kiremitci S; Gokcan H; Ulas B; Ellik Z; Ozercan M; Er RE; Karakaya F; Bodakci E; Erden A; Elhan AH; Savas B; Loomba R; Idilman R Eur Radiol; 2024 Jun; 34(6):3882-3888. PubMed ID: 37987833 [TBL] [Abstract][Full Text] [Related]
16. A review regarding the article 'Electrocardiographic abnormalities in patients with metabolic dysfunction-associated Steatotic liver disease: A systematic review and meta-analysis.'. Li C; Wang T; Song J Curr Probl Cardiol; 2024 Jul; 49(7):102626. PubMed ID: 38718937 [TBL] [Abstract][Full Text] [Related]